Overview
Kenichi Suda practices in Izumi, Japan. Mr. Suda is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 129 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Lung Metastases.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung Cancer
- Lung CancerMr. Suda isElite. Learn about Lung Cancer.
- Distinguished
- Lung AdenocarcinomaMr. Suda isDistinguished. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Suda isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Small Cell Lung Cancer (SCLC)Mr. Suda isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Adenoid Cystic CarcinomaMr. Suda isExperienced. Learn about Adenoid Cystic Carcinoma.
- Lung MetastasesMr. Suda isExperienced. Learn about Lung Metastases.
- Lung NodulesMr. Suda isExperienced. Learn about Lung Nodules.
- Neuroendocrine TumorMr. Suda isExperienced. Learn about Neuroendocrine Tumor.
- Squamous Cell Lung CarcinomaMr. Suda isExperienced. Learn about Squamous Cell Lung Carcinoma.